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ABSTRACT We investigated the electrophysiological signature of neuroactive steroid interactions with the plasma membrane.
We found that charged, sulfated neuroactive steroids, those that exhibit noncompetitive antagonism of GABAA receptors,
altered capacitive charge movement in response to voltage pulses in cells lacking GABA receptors. Uncharged steroids, some
of which are potent enhancers of GABAA receptor activity, produced no alteration in membrane capacitance. We hypothesized
that the charge movements might result from physical translocation of the charged steroid through the transmembrane voltage,
as has been observed previously with several hydrophobic anions. However, the charge movements and relaxation time
constants of capacitive currents did not exhibit the Boltzmann-type voltage dependence predicted by a single barrier model.
Further, a ﬂuorescently tagged analog of a sulfated neurosteroid altered membrane capacitance similar to the parent compound
but produced no voltage-dependent ﬂuorescence change, a result inconsistent with a strong change in the polar environment of
the ﬂuorophore during depolarization. These ﬁndings suggest that negatively charged sulfated steroids alter the plasma
membrane capacitance without physical movement of the molecule through the electric ﬁeld.
INTRODUCTION
Neuroactive steroids act potently and apparently directly to
either potentiate or antagonize the actions of GABA acting at
GABAA receptors. Potentiating steroids are uncharged and
highly lipophilic, with log P values suggesting that steroids
could accumulate in the plasma membrane at 10,000–100,000
times the concentration found in aqueous solution, although
this has never been measured directly. This accumulation is
likely relevant to potentiating steroid actions because binding
sites for anesthetic neuroactive steroids were identified re-
cently within transmembrane domains of the GABAA re-
ceptor (1), and our work has recently stressed the importance
of membrane and intracellular accumulation to the longevity
and the potency of receptor modulation (2–4).
By contrast, the most potent GABA-antagonist steroids are
sulfated at carbon 3, of the steroid A-ring (5,6). The anionic
charge of sulfated steroids keeps this class of neurosteroid
from passing directly through the plasma membrane, at least
at sufficiently low concentrations (7), but some of the sulfated
steroids exhibit voltage dependent block of GABAA recep-
tors (8), suggesting the possibility of physical voltage-
dependent translocation of the molecule across the bilayer, as
occurs with other charged lipophilic molecules (9–16).
These considerations suggest two ways in which GABA-
active steroids might interact with the plasma membrane and
that might be detected electrophysiologically. First, steroids
might intercalate into the membrane in a way that alters the
membrane capacitance, without voltage-dependent physical
translocation of the steroid. This might occur, for instance,
if steroids alter packing density of membrane lipids. Second,
if the negatively charged sulfate group of antagonist ste-
roids directly senses the transmembrane potential, capacitive
charge movement might be generated as a result of the
physical translocation of the charge across a fraction of the
bilayer and through the transmembrane electrical field.
We tested uncharged and charged steroids with actions at
GABAA receptors and found that only negatively charged
sulfated pregnane steroids altered membrane capacitance of
Xenopus oocytes and human embryonic kidney 293 (HEK)
cells. Sulfated steroids did not affect membrane resistance.
Effects on membrane capacitance did not require presence of
GABA receptors. The unique effects of the charged steroids
suggested the hypothesis that sulfated steroids may be phys-
ically translocated through the transmembrane electric field.
In contrast to Boltzmann predictions that arise from this
hypothesis, we observed little or no voltage dependence to
the charge or time constants of current responses to voltage
pulses over a wide range of membrane potentials. Further, a
fluorescently tagged sulfated steroid, predicted to alter its fluo-
rescence as the hydrophobicity of the fluorophore environ-
ment changes, exhibited no voltage-dependent fluorescence
change. These data suggest that the main electrophysiologi-
cally detectable effect of neuroactive steroids is that of an
altered membrane capacitance, imparted by antagonist sul-
fated pregnane steroids but not by hydroxypregnane poten-
tiating steroids. We conclude that sulfated steroids, probably
by adsorption to the membrane, alter the physical properties
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of the membrane to increase membrane capacitance, but
without physical translocation of the anion. We speculate on
the relevance to steroid modulation of ion channels.
MATERIALS AND METHODS
Compounds
Except for the tagged analog in Figs. 5 and 6 and the enantiomer of preg-
nenolone sulfate (17), steroids used in the studies were commercially avail-
able and obtained from Sigma-Aldrich (St. Louis, MO) or from Steraloids
(Newport, RI). Commercially available steroids were pregnenolone sulfate;
(3a,5b)-3-hydroxypregnan-20-one, also called pregnanolone and herein
abbreviated 3a5bP; (3a,5b)-3-hydroxypregnan-20-one sulfate (3a5bPS);
(3b,5a)-3-hydroxypregnan-20-one (3b5aP); and (3b,5a)-3-hydroxypregnan-
20-one (3b5aPS). A (7-nitro-2,1,3-benzoxadiazol-4-yl)amino group was at-
tached to carbon 2 of 3b5aPS to create a fluorescent sulfated steroid as described
(C2-NBD 3b5aPS) (18). Full synthetic details will be given elsewhere. Other
compounds were from Sigma.
Oocyte recordings
Stage V to VI oocytes were used for all physiology. Oocytes were harvested
from sexually mature female Xenopus laevis frogs (Xenopus One, Northland,
MI) under anesthesia, according to institutionally approved protocols. Oo-
cytes were defolliculated by shaking for 20 min at 37C in calcium-free saline
solution containing collagenase (2 mg ml1). Capped mRNA, encoding rat
GABAA receptor subunits a1, b2, and g2L was transcribed in vitro using the
mMessage mMachine kit (Ambion, Austin, TX) as described previously (19).
cRNA (30 ng total, 1:1:1 subunit ratio) was injected 24 h after defolliculation,
and recordings were carried out 24–96 h after RNA injection. g2 subunit
expression was verified by benzodiazepine (1mM lorazepam) potentiation of
responses to 2 mM GABA. Oocytes were cultured at 18C in solution con-
taining (in mM): NaCl 96, KCl 1, MgCl2 1, CaCl2 2, and HEPES 10 at pH 7.4,
supplemented with pyruvate (5 mM), penicillin (100 U ml1), streptomycin
(100 g ml1), and gentamycin (50 g ml1).
Oocytes were clamped using a virtual-ground two electrode voltage clamp
(Warner OC-725C amplifier, Warner Instruments, Hamden, CT). Pipettes
were filled with 3 M KCl. Bath solution included (in mM) NaCl 96, KCl 1,
MgCl2 1, CaCl2 2, and HEPES 10 at pH 7.4. Data were collected using a
Digidata 1322 analog/digital converter and PClamp 9 software (Molecular
Devices, Sunnyvale, CA). Responses to voltage pulses were collected at open
bandwidth and digitized at 50 kHz.
For most studies, we used oocytes uninjected with RNA to isolate mem-
brane effects of the neurosteroids examined. We found no effect of the pres-
ence of GABAA receptors on the capacitive currents studied herein. Methods
for estimating oocyte capacitance in the presence and absence of sulfated
steroids are described in Results. For estimating charge displacement re-
sulting from tetraphenylborate application to oocytes, we incubated oocytes
overnight in 100 mM tetraphenylborate to allow drug to equilibrate with the
membrane. Shorter tetraphenylborate applications of up to 2 h were not
sufficient to produce capacitance changes. Unlike control oocytes, whose
capacitance current relaxations were well described by a single exponential,
current transients in tetraphenylborate-treated cells required a bi-exponential
fit (see Fig. 4 C, inset). The fast component was similar to the single com-
ponent of control cells and was assumed to be associated with basal, en-
dogenous membrane capacitance. The slow component was assumed to
represent voltage-dependent displacement of tetraphenylborate, and this
component was quantified in Fig. 4, C and D. For HEK cell experiments with
tetraphenylborate (Supplementary Material, Fig. S1), we detected tetraphe-
nylborate-induced capacitance changes with lower concentrations and within
5 min of incubation (Fig. S1). These changes did not differ from those pro-
duced by overnight HEK-cell incubation in tetraphenylborate.
Cell cultures
Primary neuronal/astrocyte cultures were prepared from postnatal day 0–3 rat
hippocampus as described previously (20). Cells were dissociated by papain
treatment followed by mechanical dispersion onto collagen-coated 35 mm
culture dishes. Culture medium was modified Eagle’s medium (Invitrogen,
Gaithersburg, MD) supplemented with heat-inactivated horse serum (5%),
fetal bovine serum (5%), 17 mM glucose, 400 mM glutamine, 50 U/ml
penicillin, and 50mg/ml streptomycin. Cultures grew at 37C in a humidified
incubator equilibrated with 5% CO2/95% air. Cytosine arabinoside (6.7mM)
was added 3–4 days after plating to inhibit glial division. At 4–5 days after
plating, medium was supplemented by a 1/2-volume replacement with
Neurobasal medium (Invitrogen) plus B27 supplement. Cultures were im-
aged 7–12 days after plating using conventional epi-fluorescence during
application of C2-NBD 3b5aPS (18). A total of 1–6 mM C2-NBD 3b5aPS
was applied by local bath perfusion through a multi-barrel pipette placed
within 0.5 mm of the recorded cell. These high concentrations sometimes
resulted in significantly more intracellular fluorescence (see Fig. 5) than
evident at lower concentrations, where fluorescence is primarily localized to
the plasma membrane (18). Emission at 535 nM was collected and analyzed
using a 403 0.8 N.A. objective and a CoolSnap ES2 camera (Photometrics,
Tucson, AZ). Alternatively, 0.5 mM Bis-(1,3- dibutylbarbituric acid) tri-
methine oxonol (DiBAC4(3)) was applied. Images were acquired at the end
of 20–30 s dwell time at the indicated voltages. Metamorph software (Mo-
lecular Devices) was used to quantify fluorescence intensity in cellular re-
gions of interest.
HEK293 cells were grown on 35 mm culture dishes in DMEM medium
with 10% fetal bovine serum and 1 mM glutamine. Small to medium-sized,
isolated cells were selected for study. We avoided cells making physical
contact with other cells to negate influences of gap junction coupling on the
responses to voltage pulses.
Whole-cell recordings
Whole-cell recordings were made from neurons and HEK cells in a recording
bath solution containing (in mM) 140 NaCl, 4 KCl, 1 MgCl2, 2 CaCl2, 10
glucose, and 10 HEPES pH 7.3. The whole-cell pipette contained 130 cesium
methanesulfonate, 4 NaCl, 0.5 CaCl2, 5 EGTA, and 10 HEPES pH 7.25.
Pipettes were pulled from borosilicate glass and had open tip resistances
when filled with the recording solution of 1.5–4 M V (HEK cells) and 3–6
M V (neurons). Voltage was controlled using an Axopatch 200B amplifier
(Molecular Devices) interfaced to a personal computer running PClamp 9
software (Molecular Devices) via a Digidata 1322 analog/digital converter
(Molecular Devices). For capacitance measurements, pipette capacitance
was zeroed completely using the fast capacitance compensation circuitry of
the amplifier before rupturing the membrane. Data were filtered at 10 kHz
using the 4-pole Bessel filter of the amplifier and were digitized at 20–200
kHz. Ten kHz and 100 kHz low-pass filter bandwidths were compared in a
subset of recordings. Estimates of time constants were within 7.6 6 3% (a
difference of 11.4 ms on average); therefore, data were analyzed using a 10
kHz filter bandwidth.
All imaging and electrophysiology experiments were done at room
temperature (23C). Student’s t-test (paired or unpaired as appropriate) was
used to evaluate statistical significance. All descriptive statistics in text and
graphs are presented as mean 6 SE.
RESULTS
We used voltage-clamped Xenopus oocytes to evaluate the
electrophysiological signature of steroid interactions with
GABAA receptors and with the plasma membrane. Fig. 1, A
and B, shows canonical effects of an exemplar 3a-hydroxy-
pregnane steroid, pregnanolone (3a5bP; Fig. 1 A), and a
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noncompetitive GABAA receptor steroid antagonist, preg-
nanolone sulfate (3a5bPS; Fig. 1 B). The compounds were
evaluated in oocytes injected with cRNA encoding rat
a1b2g2L GABAA receptor subunits. Both steroid effects on
GABA receptors are well documented by previous literature
(21). Fig. 1 A shows potentiation to a moderately low con-
centration of GABA (4 mM). At this GABA concentration,
10 mM 3a5bPS produced;40% inhibition, characteristic of
effects of many sulfated steroids at this concentration (7,22)
(Fig. 1 B).
These same steroids were investigated for nonspecific
plasma membrane interactions using voltage-pulse protocols
in naı¨ve oocytes (not injected with exogenous RNA). Voltage
pulses from 70 mV to 190 mV yielded fast capacitive
currents that were unaltered by the presence of the hydroxy-
steroids (Fig. 1 C) but were detectably altered in the presence
of the sulfated steroid (Fig. 1 D). Specifically, subtractions of
current responses in the absence of drug from current re-
sponses in the presence of drug showed drug-induced out-
ward transient currents on depolarization, and inward
transient currents on repolarization (Fig. 1 D).
We examined the effect of altering the stereochemistry of
the substituent at carbon 3 and the hydrogen atom at carbon 5.
The 3b configuration of the hydroxysteroid renders it inef-
fective as a potentiator at GABAA receptors (21). Similar to
3a5bP, 3b5aP failed to detectably alter membrane capaci-
tance (Fig. 1 E). Again, the sulfated compound with 3b and
5a stereochemistry yielded large transients (Fig. 1 F). Nei-
ther 3a5bPS nor 3b5aPS reliably altered any ionic currents
(that are minimal in oocytes) in response to the depolarization
(Fig. 1, D and F). Therefore, it is unlikely that the sulfated
steroids produced their effects on capacitive currents by
FIGURE 1 Effects on membrane properties of steroid
potentiators and antagonists of GABAA receptor function.
(A) In voltage-clamped oocytes (70 mV) expressing the
a1b2g2L GABAA receptor subunit combination, GABA
(4 mM) application for the period denoted by the horizontal
bar generated an inward current (thin trace) that was
potentiated by the co-application of 0.5 mM 3a5bP (thick
trace). Mean potentiation in 3 cells was 5.7 6 0.7-fold
above the baseline GABA response. (B) In the same oocyte
as A, the sulfated neurosteroid 3a5bPS (10 mM) antago-
nized the GABA response by ;40%. The structures of the
relevant steroids are shown below the panels. In four cells
the average inhibition was 386 2%. (C–F) Steroid-induced
capacitive current changes in an oocyte not expressing
GABA receptors. Top traces in each panel represent the
voltage protocol. Middle traces represent raw current re-
sponses to the pulse protocol; responses obtained in plain
saline and in 50mM of the indicated drug are superimposed.
Bottom traces represent digital subtraction of the baseline
trace from the drug trace. (C) In the bottom trace, the
negligible current responses represent current attributable to
50 mM 3a5bP, because baseline currents to the same
voltage pulse have been subtracted away. (D) The same
experiment carried out using the sulfated neurosteroid (50
mM) showed that the drug induced significant changes in
the transient current responses to voltage pulses. (E and F)
The same protocol as that used in C and D, except with a
pair of neurosteroids with different stereochemistry at
carbons 3 and 5. (G and H) Summary of the charge integral
obtained by integrating the transient current onsets in traces
like those in C–F (n ¼ 3–9 oocytes for each bar). Note that
uncharged steroids (left bar of each pair) did not generate a
significant alteration (p. 0.05 compared with 0 change) in
capacitive charge movement but that sulfated steroids (right
bar) did (p , 0.01 compared with 0 change). The 3b5a
sulfated steroid (F and H) generated significantly larger
alterations in capacitive currents than its diastereomer (D
and G; *p , 0.05 sulfated versus unsulfated).
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altering the gating of endogenous voltage-gated currents in
the oocytes.
Fig. 1, G and H, summarize the total drug-induced charge
transfer obtained from drug subtractions like those shown in
Fig. 1, C–F, for the four compounds investigated, integrated
over 1 ms from the onset of the voltage step. Neither hy-
droxysteroid generated alterations in capacitive transients
that deviated significantly from zero. By contrast, both of the
corresponding charged, sulfated steroids generated signifi-
cant alterations of oocyte capacitive transients. Because
3b5aPS yielded transients approximately fivefold larger than
3a5bPS, we focused our attention on the 3b sulfate for
subsequent studies.
Fig. 2 A shows details of the 3b5aPS effect and clarifies
the characteristics of the raw capacitive currents from which
the subtracted traces in Fig. 1, C–F, were generated. The
currents in Fig. 2 A represent transients in response to the
initial step from 70 mV to 190 mV in the absence (dotted
line) and presence (solid line) of 3b5aPS (same cell as Fig.
1 F). The change in current transients caused by drug implies
a change in membrane capacitance. To estimate the change in
membrane capacitance imparted by the sulfated steroid, we
took membrane capacitance to equal
C ¼ Q=DV: (1)
C represents membrane capacitance, Q the charge displace-
ment, and DV the imposed voltage change. To estimate Q
while minimizing the contributions of errors in the peak
amplitude of capacitance transients induced by filtering via
circuitry and pipette resistances, we fit the decay of onset
capacitive transients with a single exponential from 10% of
the peak and extrapolated the fit to the instant of the voltage-
pulse onset (Fig. 2 B, solid line). The area under the fit
(shaded area of Fig. 2 B) was then calculated to yield an
estimate of charge displacement, which was used to calculate
capacitance by Eq. 1. By this method, oocyte membrane
capacitance was calculated to be 2536 12 nF from a sample
of 11 oocytes, consistent with estimates of oocyte capaci-
tance obtained by varied methods (23,24). 3b5aPS (50 mM)
increased the membrane capacitance by 5 6 2% (p , 0.05,
paired t-test; Fig. 2 B inset).
Interestingly, with 50 ms pulses the capacitance change
produced by the onset of pulses to 190 mV were not sym-
metrical with the return (offset) transient produced by the step
back to 70 mV. With 50 ms pulses to 190 mV, there was
consistently more charge recovered with the pulse offset
compared with pulse onset; subtracted transients generated
by the return pulse to 70 mV generated 45 6 9% more
charge transfer than the onset pulse generated (n ¼ 3; Fig. 2 C,
p , 0.05 compared with 0 change). In these same oocytes,
when the pulse duration was decreased to 10 ms, the recov-
ered charge at pulse offset was within 3 6 2% of the onset
transient (Fig. 2 D; not significantly different than 0 change).
There was absolutely no asymmetry to baseline capacitive
charge movements in these cells in the absence of drug (0 6
0% difference in offset transients versus onset transients, n ¼
3). We interpret the asymmetry in subtracted transients with
long pulses to reflect a slow drug-induced charge movement
accumulated at the positive membrane potential that was
recovered quickly by the return pulse. It is possible that the
slow charge accumulation may represent slow asymmetric
partitioning of the steroid. However, we did not observe the
same asymmetry in another cell type. Patch clamped HEK
cells showed no asymmetry in charge recovery with the same
voltage protocol (data not shown). We conclude that the
phenomenon is oocyte specific and therefore not likely rel-
evant to receptor modulation or other cellular effects of the
steroid. The asymmetry was not investigated further.
The sulfated pregnane steroid investigated in Figs. 1 and 2
shows voltage-dependent inhibition of GABA currents,
whereas pregnenolone sulfate, a commonly used GABAA
receptor antagonist steroid, exhibits no voltage dependence
(7,25). Pregnenolone sulfate also altered capacitive currents in
a fashion that was similar, though slightly smaller in mag-
nitude, compared with those generated by 3b5aPS (charge
FIGURE 2 Estimates of capacitive change and conservation of charge in
oocytes. (A) Raw, unsubtracted traces of the onset current in response to a
160 mV voltage pulse from 70 mV. The dotted trace shows the transient
current response under baseline conditions (absence of drug). The solid trace
shows the current response in the presence of 50 mM 3b5aPS. (B) Replot of
the dotted trace (absence of steroid) from A showing a single exponential fit
(solid line) superimposed on the relaxation of the transient, extrapolated to
the onset of the voltage pulse to 190 mV. The shading under the fit
represents the integral used to calculate total charge displaced. The inset
shows the estimate of cell capacitance (total charge displaced, normalized to
the amplitude of the voltage pulse) in the absence (black bar) and presence
(white bar) of 3b5aPS. *p , 0.05, paired t-test, n ¼ 11 oocytes. (C and D)
The traces are superimposed subtractions (50 mM 3b5aPS minus baseline
saline) showing the transient response to pulse onset (solid line) to190 mV
and offset (dotted line) on return to 70 mV. The offset responses have been
inverted and superimposed for comparison with the onset responses. For
long voltage pulses the charge observed on step back to 70 mV was larger
than the charge at onset, but for short pulses charge was nearly completely
conserved.
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with a 160 mV step in potential was 8.2 6 1.1 nC for preg-
nenolone sulfate and 11.5 6 1.3 nC for 3b5aPS in the same
oocytes; 50 6 16% difference, p ¼ 0.01, n ¼ 8). Because
both steroids generated relatively large capacitance changes,
we conclude that steroid-induced charge movement altera-
tions do not track qualitatively with voltage-dependent ef-
fects on GABAA receptors.
Fig. 3 shows the concentration dependence of steroid-in-
duced charge movements. There was no clear dependence of
the time constant of current relaxation on 3b5aPS concen-
tration (Fig. 3 A). However, both the amplitude (Fig. 3 B),
extrapolated from fits to subtracted traces, and total charge
transfer (Fig. 3 C) exhibited dependence on drug concen-
tration. Interestingly, the concentration dependence of these
effects was saturable and was reasonably well described by
the Hill equation (Fig. 3, B and C) with EC50 concentrations
of 39 mM and 27 mM for charge and amplitude respectively
and slope values of 1.2 and 1.4 (Fig. 3, B and C, solid lines).
Higher concentrations could not be examined because of
poor drug solubility.
The saturability with high concentrations might suggest
that the capacitive changes are associated with binding to a spe-
cific site, e.g., a receptor. If bilayer interactions, rather than a
proteinaceous binding site are important in the steroid-
induced charge movements, we might expect little enantiose-
lectivity of charge movements. Because we have synthesized
an enantiomer of pregnenolone sulfate previously (17), we
directly compared the ability of the natural and unnatural
enantiomer to alter membrane capacitive currents in oocytes.
Fig. 3 D shows currents generated by 50 mM pregnenolone
sulfate and its unnatural enantiomer. Charge displacements
from the unnatural enantiomer were not statistically distin-
guishable from those associated with pregnenolone sulfate
itself in the same oocytes (2 6 4% smaller; p ¼ 0.8, n ¼ 6).
Accordingly, neither the amplitude nor the time constants of
the drug associated changes differed between pregnenolone
sulfate and its enantiomer (data not shown).
We also tested whether surface charge influences the in-
teraction of sulfated steroid with the plasma membrane. We
manipulated surface charge screening by decreasing the
concentration of divalent cations in the extracellular bath
solution to 10% of normal (0.2 mM Ca21 and 0.1 mM
Mg21). We found that this manipulation had little effect on
drug-induced capacitive change (12 6 5%, n ¼ 4).
In summary, sulfated pregnane steroids and pregnenolone
sulfate, but not hydroxypregnane steroids, alter current tran-
sients in response to voltage pulses in Xenopus oocytes.
Because only charged neurosteroids affected membrane ca-
pacitance, we explored the effect of sulfated steroids in more
detail. We hypothesized that voltage-dependent translocation
of the negatively charged steroid across a fraction of the bi-
layer might account for the drug-induced capacitive currents
observed.
If drug-induced capacitive currents result from transloca-
tion of the charged steroid between two membrane energy
minima within the lipid bilayer, we expect that charge
movements should obey behavior documented previously
pertaining to charged hydrophobic ions (9–16). Among the
predictions is a sigmoidal dependence of equilibrium charge
transfer (DQ) on membrane potential (V):
DQ=DQmax ¼ 1
11 exp
ebðV  VhÞ
kT
: (2)
Vh represents the potential at which there are equal numbers
of ions in each potential energy well, b is the fraction of the
potential difference experienced by the translocating mole-
cule, and k, T, and e have their usual meanings of Boltzmann
constant, temperature Kelvin, and elementary charge per ion.
In the case of 3b5aPS, the charge movement was nearly
linear over the range of voltages accessible with the voltage-
clamp amplifier, with only a trend toward deviation at the
most deeply negative voltages (Fig. 4 A). The best sigmoidal
fit from Eq. 2 is superimposed on the data in Fig. 4 A, but in
fact none of the raw data points deviated significantly from
a linear regression fit to the data between 40 and1 40 mV
(p . 0.05, paired t-test, n ¼ 5; raw data versus linear re-
gression prediction).
FIGURE 3 Concentration dependence of time constant (A), amplitude
(B), and charge displacement (C) of transient onset currents. Estimates were
obtained from subtraction currents. Subtracted relaxations were fit to a single
exponential and extrapolated to the onset of the voltage pulse for estimates
of amplitude and charge. Solid lines in B and C represent best fits of the
concentration-response data to the Hill equation. n ¼ 4 oocytes challenged
with all four concentrations of 3b5aPS. (D) Lack of enantioselectivity of
charge movements. Pregnenolone sulfate and its enantiomer were evaluated
at 50 mM on the same oocyte. Drug minus baseline subtraction traces are
shown (dotted lines) along with a portion of the exponential fit used to
quantify drug-associated capacitive current amplitude (fit extrapolated to
time zero), time constant, and total charge displacement. In this example,
pregnenolone sulfate charge displacement was 1.84 nC and ent-pregneno-
lone sulfate charge displacement was 1.80 nC. Time constants were 234 ms
and 232 ms, respectively.
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Similarly the time constant of capacitive current relaxa-
tions should exhibit a bell-shaped dependence on membrane
potential:
DtðVÞ ¼ tmaxtanh ebðV  VhÞ
 
2kT
: (3)
Fig. 4 B shows the relationship between the steroid-induced
capacitive transient time constant versus applied membrane
potential. There was no detectable dependence of time con-
stant on voltage, compared with previously reported charged
lipophilic molecules (9–16). In particular, although there is
doubt about the applicability of energy minima models to our
data, at face value, fits in Fig. 4, A and B, suggest a small
value for b, indicating that the steroid senses only a very
small fraction of the transmembrane potential.
As a comparison, we examined the profile of tetraphe-
nylborate, a well characterized hydrophobic anion (10,11,14).
We found the expected sigmoidal behavior of charge
displacement on voltage and the expected bell-shaped de-
pendence of time constant on voltage (Fig. 4, C and D). In-
terestingly, oocytes exhibited a negatively shifted Vh value in
charge versus voltage plots (Fig. 4 C) compared with previous
studies of tetraphenylborate in artificial membranes and other
cells (10,11,14). We attribute this to strong intracellular
accumulation of the anion with the overnight incubation
necessary to show capacitance changes (see Materials and
Methods). We hypothesize that intracellular accumulation
created a concentration gradient that favored an inner mem-
brane leaflet distribution of anion. In support of this hypoth-
esis, oocytes incubated overnight in the colored hydrophobic
anion oxonol showed visible local depletion of the drug in the
unstirred layer surrounding individual oocytes (data not
shown). Furthermore, smaller HEK cells exhibited rapid tet-
raphenylborate-induced capacitance changes (within 5 min),
and had Vh values closer to 0 mV (Fig. S1). Overnight incu-
bation of oocytes in 100 mM 3b5aPS produced no sign of
altered or increased capacitance changes over those produced
by the brief incubations used in our studies (n ¼ 5 control
and 5 3b5aPS-treated oocytes, data not shown). Despite the
difference in quantitative behavior of tetraphenylborate in
oocytes compared with other systems, these results highlight
a fundamental qualitative difference between a classically
described hydrophobic anion and the sulfated steroids.
The lack of apparent voltage dependence of steroids sug-
gests that the sulfated steroids are unlikely to translocate,
either because the negative charge orients in a way that does
not sense the transmembrane voltage, or because steroid is
relatively immobilized in the membrane. To test this hypothesis,
we turned to optical methods. Specifically, voltage-dependent
translocation within the bilayer of charged fluorescent lipo-
philic molecules alters the fluorescence of the fluorophore
reporter, an effect that has been used to provide an optical
measure of membrane potential (26–28). Although not spe-
cifically used as a voltage sensor, NBD-tagged conjugates,
including steroid-like molecules, increase fluorescence with
increasing hydrophobicity of the solvent environment (29,
30). To provide an independent test of our conclusion that
sulfated neurosteroids do not translocate across the bilayer,
we tagged 3b5aPS with a fluorescent NBD group (C2-NBD
3b5aPS) (18) and tested for voltage-dependent changes in
cellular fluorescence. We first verified that the tagged steroid
analog obeyed the same hydrophobicity-dependent fluores-
cence changes as free NBD. Consistent with results with
other NBD-conjugates, we found that C2-NBD 3b5aPS in-
creased its fluorescence emission (measured at 535 nM) in
ethanol compared with water by 4.6- and 5.4-fold respec-
tively in two separate experiments.
We tested for fluorescence changes on primary cultures of
hippocampal neurons, which allowed for more feasible
imaging than the much larger oocytes. When tested on live,
voltage-clamped hippocampal neurons, we found no change
in fluorescence with the NBD-conjugated steroid when
FIGURE 4 Charge displacements and time constants lack voltage depen-
dence. Measurements were made from subtracted onset currents in response
to steps from 70 mV. (A) Drug-induced onset charge estimates showed
nearly linear (solid circles, n ¼ 5 oocytes), rather than sigmoidal (solid fit
line), dependence on membrane potential. (B) The time constants of drug-
induced current relaxations did not show the expected bell-shaped depen-
dence on membrane potential. Estimates of charge and time constants were
obtained from subtraction currents, which were fit with single exponential
functions extrapolated to the instant of the voltage-pulse onset. The solid
lines in A and B are fits to Eqs. 2 and 3, respectively. Fit parameters were b¼
0.3 and Vh ¼ 92 mV (A) and tmax ¼ 1.03 ms, b¼ 0.12, and Vh ¼ 0.0 mV (B).
(C and D) Positive control experiment using oocytes exposed to tetraphe-
nylborate (100 mM). The inset in C shows representative capacitive currents,
with the first 600 ms of capacitive current blanked, showing tetraphenyl-
borate-induced changes in the absence of fast, endogenous capacitive cur-
rents. Voltage pulses were from a holding potential of 30 mV and were
made to voltages between 200 mV and 1 200 mV in 20 mV increments.
The solid circles in C represent slow charge displacements, isolated with bi-
exponential fits to the total capacitive transients of four oocytes. The solid
line is a fit to Eq. 3 with fit parameters of b ¼ 0.7 and Vh ¼ 78.7 mV. See
Results for an interpretation of the negative Vh value. Time constants of the
slow component of capacitive transients are plotted in D. The solid line is a
fit to Eq. 3 with tmax ¼ 35.6 ms, b ¼ 0.6, and Vh ¼ 0 mV.
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membrane potential was pulsed from 70 mV to 140 mV
for 20–30 s. The ratio of fluorescence at 140 mV relative to
70 mV from 12 regions of proximal dendrite from four cells
treated with 3–6 mM of the fluorescent analog was 0.98 6
0.1. By contrast, the well-characterized voltage-dependent
fluorescent anion bis(1,3-dibutylbarbituric acid)trimethine
oxonol ½DiBAC4(3) (13,28), with spectral properties similar
to those of NBD, exhibited strong voltage-dependent changes
in fluorescence under the same conditions (Fig. 5 B; 140/
70 mV ratio of 2.66 0.2 in 11 membrane regions from six
cells, p , 0.05 compared with C2-NBD 3b5aPS). The in-
tracellular fluorescence observed in DiBAC4 (3) cells did not
change with voltage (ratio 0.92 in two cells).
We also verified the ability of the NBD-tagged sulfated
steroid to alter membrane capacitance. Because of limited
quantities of available tagged steroid, we used human em-
bryonic kidney cells for evaluation rather than Xenopus oo-
cytes. The smaller HEK cells allowed use of local perfusion
for drug delivery rather than oocyte bath exchange, dramat-
ically reducing the amount of compound required. The use of
another cell type and alternative voltage-clamp technique
(whole-cell patch clamp) also afforded us the opportunity to
verify several salient results from oocytes.
Like oocytes (but unlike neurons), HEK cells can be ap-
proximated electrically by a simple circuit: parallel membrane
resistance and capacitance linked to the voltage clamp
through an access resistance much lower than the membrane
resistance (31). The simple equivalent circuit results from
uncomplicated membrane geometry, especially a lack of
dendrites and axons. Fig. 6 A shows baseline capacitive
transients in HEK cells; whole-cell voltage clamp was used to
step membrane potential from 70 to 120 mV. A cesium-
based pipette solution was used to increase membrane resis-
tance and to block contributions of voltage-gated potassium
channels. Baseline transients were well fit by a single expo-
nential (Fig. 6 A, inset, solid gray line), confirming their
FIGURE 5 Lack of voltage-dependent fluorescence change with a sul-
fated NBD-tagged analog. (A1 and A2) Fluorescence images obtained in the
presence of 3 mM C2-NBD 3b5aPS at membrane potentials of 70 mV
(left) and after 20 s at140 mV (right). Voltage was controlled with a whole-
cell patch pipette visible as a shadow on the right side of the image, through
the aqueous fluorescence of the analog. Results are representative of six cells
challenged with 1–6 mM C2-NBD 3b5aPS. (Bottom panels) Positive
control using DiBAC4 (3) (0.5 mm) imaged under the same conditions as
in the top panels. The fluorescence change was reversible on re-establishing
a membrane potential of 70 mV (not shown). Scale bar represents 10 mm.
FIGURE 6 The NBD-tagged steroid C2-NBD 3b5aPS yields capacitance
changes similar to the parent compound, 3b5aPS. (A) Raw current traces in
normal saline obtained from an isolated HEK cell in response to a voltage
pulse from 70 mV to120 mV. The onset transient is shown at higher time
resolution in the inset as dotted points. The gray line is a single-exponential
fit, superimposed and extrapolated to the instant of the voltage change. The
time constant of the transient relaxation was 102 ms. The good correspon-
dence between fit and data is consistent with a representation of the cell as a
single electrical compartment (31). (B) Subtracted traces obtained from a
different cell exposed to 5 mM and 50 mM 3b5aPS. Transients in the
presence of saline wash have been subtracted. (C and D) Subtraction
currents from the cell in A. (C) Represents saline minus saline subtractions
obtained under the same experimental conditions as with drug applications
in D and E. (D) Represents subtraction of saline transients from transients
obtained in the presence of 15 mM C2-NBD 3b5aPS. (E) Represents saline
transients subtracted from transients obtained in the presence of 15 mM
3b5aPS. In the subtracted traces of C–E the first 50 ms of data at the onset
and offset of the voltage pulse have been blanked to eliminate small, fast,
capacitive changes resulting from bath level changes. The voltage protocol
and calibration bars in C apply to C–E. (F and G) Summary (n ¼ 8 HEK
cells) of steroid-induced capacitance changes (F) and time constants of the
capacitance changes (G) in HEK cells using the voltage protocol shown in
A. Compounds were used at 15 mM. C2-NBD 3b5aP yielded a slightly but
significantly higher change in capacitance than the parent steroid (p ¼ 0.03).
There was no difference in drug-induced relaxation time constant (p. 0.09).
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compact, single-compartment structure (31). HEK cell base-
line capacitance was 34.5 pF, and the time constant was 1546
30ms (n ¼ 8 cells). 3b5aPS altered membrane capacitance in
a manner similar to that observed in oocytes (Fig. 6 B). Ca-
pacitive transients were concentration dependent, with 5 mM
3b5aPS increasing membrane capacitance by 2% 6 1% of
the baseline and 50 mM increasing the capacitance by 12 6
2% (n ¼ 7).
To compare capacitance change induced by 3b5aPS and
by the NBD-tagged analog, we compared the two drugs on the
same cell at equimolar concentrations (15–50 mM). C2-NBD
3b5aPS produced similar or slightly higher alterations in
capacitive current to those produced by 3b5aPS (Fig. 6,
C–G). These results therefore verify that the tagged sulfated
steroid behaves similarly to the parent compound with regard
to effects on membrane capacitance. The results also extend
our primary oocyte findings to mammalian cells.
DISCUSSION
Our results suggest that charged steroids interact with cells in
a way that alters membrane capacitive properties. This in-
teraction is distinct from interactions between uncharged
neurosteroids and the membrane, and it apparently does not
result from voltage-dependent charge movement of the an-
ionic sulfate group itself. It is possible that these membrane
interactions are important for the modulation of membrane
channels, most notably the GABAA receptor, which is an-
tagonized over the concentration range of sulfated steroids
explored here.
Our evidence suggests that sulfated neurosteroids do not
obey predictions of two-site, single-barrier models for hy-
drophobic anion translocation. Previously investigated an-
ions include dipicrylamine (12,14,16,27), oxonols (13), and
tetraphenylborate (10,11,14). In all of these cases, behavior
of ions in synthetic membranes and living cells is well de-
scribed by single barrier models with two energy minima
representing externally facing and internally facing binding
to the membrane-solution interfaces. The dependence of
charge displacement on applied voltage is sigmoidal, and the
relationship between current relaxation time constants and
applied voltage is bell shaped. Both of these predictions were
clearly violated in the case of the sulfated neurosteroid
3b5aPS.
Fluorescence imaging also was inconsistent with sulfated
neurosteroid translocation. We might have expected fluores-
cence changes as the translocated steroid and attached NBD
group were drawn into a more hydrophobic environment with
depolarization. Although this negative result is not, by itself,
definitive, our positive control experiments help give context
to the imaging result, and the imaging is broadly consistent
with the conclusions reached with biophysical measurements.
Considering both the electrical changes and the fluorescence
imaging, one is left with a picture of sulfated steroids ad-
sorbing to the external leaflet of the membrane and thereby
altering membrane thickness or packing order to influence the
dielectric properties of the membrane, without physical
translocation through the bilayer. A puzzling aspect of the
phenomenon is the role of negative charge; similar steroids
without a sulfate group do not detectably influence the ca-
pacitive properties of the membrane. However, cholesterol
and cholesterol sulfate apparently interact distinctly with
membranes (32,33), offering the core of a possible physical
explanation for differences between charged and uncharged
steroids.
Several other features of the capacitive changes are of note.
Although we did not observe saturation of charge displace-
ment with voltage, capacitance changes saturated at high
concentrations of steroid. One possible explanation for this
behavior is that a chiral steroid binding pocket, likely pro-
teinaceous, is important for steroid interaction with the
membrane and the resulting capacitive change. This possi-
bility is rendered less likely by the similar behavior of natural
and unnatural enantiomers of pregnenolone sulfate (Fig. 3 D).
Furthermore, saturation of capacitive currents with concen-
tration has been observed with other hydrophobic anions in
artificial bilayers (14) and has been attributed to limitations on
compound packing within the lattice of the plasma membrane,
perhaps caused by strain on membrane polar headgroups re-
sulting from adsorption of the anion.
Although all sulfated steroids tested generated capacitive
changes, there were clear differences among diastereomeric
steroid pairs. Because diastereomers, unlike enantiomers,
have different physicochemical differences, this result is not
necessarily surprising. For instance, it was shown recently
that the hydroxysteroid diastereomer pair, pregnanolone and
allopregnanolone, differ from each other in their membrane
interactions, although enantiomeric pairs do not differ sig-
nificantly (34).
What are the physiological implications of our observa-
tions? Steroid receptors are typically invoked to explain bi-
ological effects of steroids, including effects on neurons.
However, nongenomic effects of pharmacologically admin-
istered steroids include membrane effects that can influence
cell function (35,36). Likewise, the local membrane envi-
ronment has been shown to affect ion channel gating (37,38).
Because the log P value of pregnenolone sulfate is 4.81
(Advanced Chemistry Development Software V8.14, Ad-
vanced Chemistry Development, Toronto, Canada), high
millimolar concentrations of membrane steroid will likely be
achieved with pharmacologically relevant aqueous concen-
trations of sulfated steroid. High local membrane concen-
trations are consistent with the possibility of changes in
membrane properties that may affect channel function. Fur-
thermore, strong membrane solubility suggests that most
sulfated steroids measured endogenously (39–41), will de-
rive from membrane fractions.
Sulfated neurosteroids modulate several transmembrane
receptors besides the GABAA receptor. Other targets include
the NMDA receptor (42–44) and s-receptor (45). Do the
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capacitive changes reported herein have relevance to modu-
lation of these receptor classes? We first consider GABA
receptor modulation. There are tantalizing parallels between
capacitance changes and GABA receptor modulation. Al-
though virtually all sulfated steroids antagonize GABA re-
ceptors, pregnenolone sulfate and 3b5aPS seem to be
stronger antagonists than 3a5bPS (6,22), correlating with the
degree of capacitance change produced by different sulfated
steroids in these studies. GABA receptor inhibition by
pregnenolone sulfate exhibits little enantioselectivity (17);
this could suggest that a membrane effect is important for
inhibition. In addition the concentration dependence of ca-
pacitance change is not dissimilar from the concentration
response for GABA receptor antagonism or for modulation
of NMDA receptors, although this comparison is compli-
cated by the agonist concentration dependence of antagonist
potency, whereby steroid-induced inhibition increases at
higher GABA concentrations (7).
Several observations, at face value, fail to support the idea
that membrane effects are related to changes in receptor
function, but these observations have caveats. Sulfated
pregnane steroids inhibit GABA receptor function with de-
tectable voltage dependence (8). Although this is dissimilar to
the lack of voltage dependence observed in capacitance
changes, pregnenolone sulfate inhibition is similar to the ca-
pacitance changes in exhibiting no detectable voltage de-
pendence (7,25,47). Mutations have been found that affect
sulfated steroid effects on GABA receptors (25,48,49). Al-
though some of these mutations are hypothesized to directly
influence steroid binding, it is difficult to exclude the possi-
bility that the mutations instead affect transduction of distant
steroid interaction (with membrane or receptor) to confor-
mational changes that effect antagonism.
It is difficult to conceive that the membrane capacitance
changes here are directly relevant to NMDA receptor mod-
ulation, because pregnenolone sulfate and 3b5aPS potentiate
NMDA receptor function, but 3a5bPS antagonizes NMDA
receptor function (44). Relevance of capacitance changes to
other receptors/channels is also possible. For instance, sul-
fated steroids have presynaptic effects, some of which may be
mediated by sigma receptors (50). However, presynaptic
pregnenolone sulfate effects exhibit enantioselectivity (45),
unlike the capacitance changes evaluated here.
In summary, our work suggests an electrophysiological
signature of sulfated neurosteroids that differs from other
negatively charged hydrophobic membrane probes. Rather
than exhibiting behavior consistent with ion translocation
in response to the membrane voltage, sulfated steroids alter
the membrane capacitance similarly at all membrane poten-
tials. Because of strong precedent that most channel modu-
lators act through specific sites on the protein, a site-specific
mode of action remains likely for sulfated steroids. However,
our data raise the possibility that changes in membrane
properties may participate in antagonism of GABA receptor
function.
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